Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Intermediates Market Size(US$)
CAGR 2025-2031
6.3%
Market Size,2031
USD 313,420
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 217,230 million
Market Forecast in 2031(Value)
US$ 313,420 million
CAGR
6.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Intermediates market size was US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.
China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.
In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.
The global Pharmaceutical Intermediates market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Lonza
- Catalent
- Patheon
- Jubilant
- Granules
- Ganesh
- Chemcon
- BASF
- Porton
- Lianhetech
- ABA Chem
- Tianma
- Jiujiujiu
- Alpha
- Jiuzhou
- Yongtai
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- GMP
- Non-GMP
Segment by Application
- Antibiotics
- Antipyretic Analgesics
- Vitamins
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pharmaceutical Intermediates market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-GMP in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Antipyretic Analgesics in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., GMP dominance in Europe vs. Non-GMP demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Intermediates Product Scope
1.2 Pharmaceutical Intermediates by Type
1.2.1 Global Pharmaceutical Intermediates Sales by Type (2020 & 2024 & 2031)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Pharmaceutical Intermediates by Application
1.3.1 Global Pharmaceutical Intermediates Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Global Pharmaceutical Intermediates Market Estimates and Forecasts (2020-2031)
1.4.1 Global Pharmaceutical Intermediates Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Pharmaceutical Intermediates Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Pharmaceutical Intermediates Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Pharmaceutical Intermediates Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Pharmaceutical Intermediates Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Pharmaceutical Intermediates Sales Market Share by Region (2020-2025)
2.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Region (2020-2025)
2.3 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Pharmaceutical Intermediates Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Pharmaceutical Intermediates Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Pharmaceutical Intermediates Market Size and Prospective (2020-2031)
2.4.2 Europe Pharmaceutical Intermediates Market Size and Prospective (2020-2031)
2.4.3 China Pharmaceutical Intermediates Market Size and Prospective (2020-2031)
2.4.4 India Pharmaceutical Intermediates Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Pharmaceutical Intermediates Historic Market Review by Type (2020-2025)
3.1.1 Global Pharmaceutical Intermediates Sales by Type (2020-2025)
3.1.2 Global Pharmaceutical Intermediates Revenue by Type (2020-2025)
3.1.3 Global Pharmaceutical Intermediates Price by Type (2020-2025)
3.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Pharmaceutical Intermediates Sales Forecast by Type (2026-2031)
3.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2026-2031)
3.2.3 Global Pharmaceutical Intermediates Price Forecast by Type (2026-2031)
3.3 Different Types Pharmaceutical Intermediates Representative Players
4 Global Market Size by Application
4.1 Global Pharmaceutical Intermediates Historic Market Review by Application (2020-2025)
4.1.1 Global Pharmaceutical Intermediates Sales by Application (2020-2025)
4.1.2 Global Pharmaceutical Intermediates Revenue by Application (2020-2025)
4.1.3 Global Pharmaceutical Intermediates Price by Application (2020-2025)
4.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Pharmaceutical Intermediates Sales Forecast by Application (2026-2031)
4.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Application (2026-2031)
4.2.3 Global Pharmaceutical Intermediates Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Intermediates Application
5 Competition Landscape by Players
5.1 Global Pharmaceutical Intermediates Sales by Players (2020-2025)
5.2 Global Top Pharmaceutical Intermediates Players by Revenue (2020-2025)
5.3 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2024)
5.4 Global Pharmaceutical Intermediates Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Pharmaceutical Intermediates, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pharmaceutical Intermediates, Product Type & Application
5.7 Global Key Manufacturers of Pharmaceutical Intermediates, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pharmaceutical Intermediates Sales by Company
6.1.1.1 North America Pharmaceutical Intermediates Sales by Company (2020-2025)
6.1.1.2 North America Pharmaceutical Intermediates Revenue by Company (2020-2025)
6.1.2 North America Pharmaceutical Intermediates Sales Breakdown by Type (2020-2025)
6.1.3 North America Pharmaceutical Intermediates Sales Breakdown by Application (2020-2025)
6.1.4 North America Pharmaceutical Intermediates Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pharmaceutical Intermediates Sales by Company
6.2.1.1 Europe Pharmaceutical Intermediates Sales by Company (2020-2025)
6.2.1.2 Europe Pharmaceutical Intermediates Revenue by Company (2020-2025)
6.2.2 Europe Pharmaceutical Intermediates Sales Breakdown by Type (2020-2025)
6.2.3 Europe Pharmaceutical Intermediates Sales Breakdown by Application (2020-2025)
6.2.4 Europe Pharmaceutical Intermediates Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pharmaceutical Intermediates Sales by Company
6.3.1.1 China Pharmaceutical Intermediates Sales by Company (2020-2025)
6.3.1.2 China Pharmaceutical Intermediates Revenue by Company (2020-2025)
6.3.2 China Pharmaceutical Intermediates Sales Breakdown by Type (2020-2025)
6.3.3 China Pharmaceutical Intermediates Sales Breakdown by Application (2020-2025)
6.3.4 China Pharmaceutical Intermediates Major Customer
6.3.5 China Market Trend and Opportunities
6.4 India Market: Players, Segments, Downstream and Major Customers
6.4.1 India Pharmaceutical Intermediates Sales by Company
6.4.1.1 India Pharmaceutical Intermediates Sales by Company (2020-2025)
6.4.1.2 India Pharmaceutical Intermediates Revenue by Company (2020-2025)
6.4.2 India Pharmaceutical Intermediates Sales Breakdown by Type (2020-2025)
6.4.3 India Pharmaceutical Intermediates Sales Breakdown by Application (2020-2025)
6.4.4 India Pharmaceutical Intermediates Major Customer
6.4.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Lonza
7.1.1 Lonza Company Information
7.1.2 Lonza Business Overview
7.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Lonza Pharmaceutical Intermediates Products Offered
7.1.5 Lonza Recent Development
7.2 Catalent
7.2.1 Catalent Company Information
7.2.2 Catalent Business Overview
7.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Catalent Pharmaceutical Intermediates Products Offered
7.2.5 Catalent Recent Development
7.3 Patheon
7.3.1 Patheon Company Information
7.3.2 Patheon Business Overview
7.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Patheon Pharmaceutical Intermediates Products Offered
7.3.5 Patheon Recent Development
7.4 Jubilant
7.4.1 Jubilant Company Information
7.4.2 Jubilant Business Overview
7.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Jubilant Pharmaceutical Intermediates Products Offered
7.4.5 Jubilant Recent Development
7.5 Granules
7.5.1 Granules Company Information
7.5.2 Granules Business Overview
7.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Granules Pharmaceutical Intermediates Products Offered
7.5.5 Granules Recent Development
7.6 Ganesh
7.6.1 Ganesh Company Information
7.6.2 Ganesh Business Overview
7.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Ganesh Pharmaceutical Intermediates Products Offered
7.6.5 Ganesh Recent Development
7.7 Chemcon
7.7.1 Chemcon Company Information
7.7.2 Chemcon Business Overview
7.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Chemcon Pharmaceutical Intermediates Products Offered
7.7.5 Chemcon Recent Development
7.8 BASF
7.8.1 BASF Company Information
7.8.2 BASF Business Overview
7.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.8.4 BASF Pharmaceutical Intermediates Products Offered
7.8.5 BASF Recent Development
7.9 Porton
7.9.1 Porton Company Information
7.9.2 Porton Business Overview
7.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Porton Pharmaceutical Intermediates Products Offered
7.9.5 Porton Recent Development
7.10 Lianhetech
7.10.1 Lianhetech Company Information
7.10.2 Lianhetech Business Overview
7.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Lianhetech Pharmaceutical Intermediates Products Offered
7.10.5 Lianhetech Recent Development
7.11 ABA Chem
7.11.1 ABA Chem Company Information
7.11.2 ABA Chem Business Overview
7.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.11.4 ABA Chem Pharmaceutical Intermediates Products Offered
7.11.5 ABA Chem Recent Development
7.12 Tianma
7.12.1 Tianma Company Information
7.12.2 Tianma Business Overview
7.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Tianma Pharmaceutical Intermediates Products Offered
7.12.5 Tianma Recent Development
7.13 Jiujiujiu
7.13.1 Jiujiujiu Company Information
7.13.2 Jiujiujiu Business Overview
7.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Jiujiujiu Pharmaceutical Intermediates Products Offered
7.13.5 Jiujiujiu Recent Development
7.14 Alpha
7.14.1 Alpha Company Information
7.14.2 Alpha Business Overview
7.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Alpha Pharmaceutical Intermediates Products Offered
7.14.5 Alpha Recent Development
7.15 Jiuzhou
7.15.1 Jiuzhou Company Information
7.15.2 Jiuzhou Business Overview
7.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Jiuzhou Pharmaceutical Intermediates Products Offered
7.15.5 Jiuzhou Recent Development
7.16 Yongtai
7.16.1 Yongtai Company Information
7.16.2 Yongtai Business Overview
7.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Yongtai Pharmaceutical Intermediates Products Offered
7.16.5 Yongtai Recent Development
8 Pharmaceutical Intermediates Manufacturing Cost Analysis
8.1 Pharmaceutical Intermediates Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pharmaceutical Intermediates
8.4 Pharmaceutical Intermediates Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pharmaceutical Intermediates Distributors List
9.3 Pharmaceutical Intermediates Customers
10 Pharmaceutical Intermediates Market Dynamics
10.1 Pharmaceutical Intermediates Industry Trends
10.2 Pharmaceutical Intermediates Market Drivers
10.3 Pharmaceutical Intermediates Market Challenges
10.4 Pharmaceutical Intermediates Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Intermediates Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Pharmaceutical Intermediates Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Pharmaceutical Intermediates Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Pharmaceutical Intermediates Sales (K MT) by Region (2020-2025)
Table 5. Global Pharmaceutical Intermediates Sales Market Share by Region (2020-2025)
Table 6. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Pharmaceutical Intermediates Revenue Share by Region (2020-2025)
Table 8. Global Pharmaceutical Intermediates Sales (K MT) Forecast by Region (2026-2031)
Table 9. Global Pharmaceutical Intermediates Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Pharmaceutical Intermediates Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Pharmaceutical Intermediates Revenue Share Forecast by Region (2026-2031)
Table 12. Global Pharmaceutical Intermediates Sales by Type (K MT) & (2020-2025)
Table 13. Global Pharmaceutical Intermediates Sales Share by Type (2020-2025)
Table 14. Global Pharmaceutical Intermediates Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Pharmaceutical Intermediates Price by Type (USD/MT) & (2020-2025)
Table 16. Global Pharmaceutical Intermediates Sales by Type (K MT) & (2026-2031)
Table 17. Global Pharmaceutical Intermediates Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Pharmaceutical Intermediates Price by Type (USD/MT) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Pharmaceutical Intermediates Sales by Application (K MT) & (2020-2025)
Table 21. Global Pharmaceutical Intermediates Sales Share by Application (2020-2025)
Table 22. Global Pharmaceutical Intermediates Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Pharmaceutical Intermediates Price by Application (USD/MT) & (2020-2025)
Table 24. Global Pharmaceutical Intermediates Sales by Application (K MT) & (2026-2031)
Table 25. Global Pharmaceutical Intermediates Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Pharmaceutical Intermediates Price by Application (USD/MT) & (2026-2031)
Table 27. New Sources of Growth in Pharmaceutical Intermediates Application
Table 28. Global Pharmaceutical Intermediates Sales by Company (K MT) & (2020-2025)
Table 29. Global Pharmaceutical Intermediates Sales Share by Company (2020-2025)
Table 30. Global Pharmaceutical Intermediates Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Pharmaceutical Intermediates Revenue Share by Company (2020-2025)
Table 32. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2024)
Table 33. Global Market Pharmaceutical Intermediates Average Price by Company (USD/MT) & (2020-2025)
Table 34. Global Key Manufacturers of Pharmaceutical Intermediates, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Pharmaceutical Intermediates, Product Type & Application
Table 36. Global Key Manufacturers of Pharmaceutical Intermediates, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Pharmaceutical Intermediates Sales by Company (2020-2025) & (K MT)
Table 39. North America Pharmaceutical Intermediates Sales Market Share by Company (2020-2025)
Table 40. North America Pharmaceutical Intermediates Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Pharmaceutical Intermediates Revenue Market Share by Company (2020-2025)
Table 42. North America Pharmaceutical Intermediates Sales by Type (2020-2025) & (K MT)
Table 43. North America Pharmaceutical Intermediates Sales Market Share by Type (2020-2025)
Table 44. North America Pharmaceutical Intermediates Sales by Application (2020-2025) & (K MT)
Table 45. North America Pharmaceutical Intermediates Sales Market Share by Application (2020-2025)
Table 46. Europe Pharmaceutical Intermediates Sales by Company (2020-2025) & (K MT)
Table 47. Europe Pharmaceutical Intermediates Sales Market Share by Company (2020-2025)
Table 48. Europe Pharmaceutical Intermediates Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Pharmaceutical Intermediates Revenue Market Share by Company (2020-2025)
Table 50. Europe Pharmaceutical Intermediates Sales by Type (2020-2025) & (K MT)
Table 51. Europe Pharmaceutical Intermediates Sales Market Share by Type (2020-2025)
Table 52. Europe Pharmaceutical Intermediates Sales by Application (2020-2025) & (K MT)
Table 53. Europe Pharmaceutical Intermediates Sales Market Share by Application (2020-2025)
Table 54. China Pharmaceutical Intermediates Sales by Company (2020-2025) & (K MT)
Table 55. China Pharmaceutical Intermediates Sales Market Share by Company (2020-2025)
Table 56. China Pharmaceutical Intermediates Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Pharmaceutical Intermediates Revenue Market Share by Company (2020-2025)
Table 58. China Pharmaceutical Intermediates Sales by Type (2020-2025) & (K MT)
Table 59. China Pharmaceutical Intermediates Sales Market Share by Type (2020-2025)
Table 60. China Pharmaceutical Intermediates Sales by Application (2020-2025) & (K MT)
Table 61. China Pharmaceutical Intermediates Sales Market Share by Application (2020-2025)
Table 62. India Pharmaceutical Intermediates Sales by Company (2020-2025) & (K MT)
Table 63. India Pharmaceutical Intermediates Sales Market Share by Company (2020-2025)
Table 64. India Pharmaceutical Intermediates Revenue by Company (2020-2025) & (US$ Million)
Table 65. India Pharmaceutical Intermediates Revenue Market Share by Company (2020-2025)
Table 66. India Pharmaceutical Intermediates Sales by Type (2020-2025) & (K MT)
Table 67. India Pharmaceutical Intermediates Sales Market Share by Type (2020-2025)
Table 68. India Pharmaceutical Intermediates Sales by Application (2020-2025) & (K MT)
Table 69. India Pharmaceutical Intermediates Sales Market Share by Application (2020-2025)
Table 70. Lonza Company Information
Table 71. Lonza Description and Business Overview
Table 72. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. Lonza Pharmaceutical Intermediates Product
Table 74. Lonza Recent Development
Table 75. Catalent Company Information
Table 76. Catalent Description and Business Overview
Table 77. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Catalent Pharmaceutical Intermediates Product
Table 79. Catalent Recent Development
Table 80. Patheon Company Information
Table 81. Patheon Description and Business Overview
Table 82. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Patheon Pharmaceutical Intermediates Product
Table 84. Patheon Recent Development
Table 85. Jubilant Company Information
Table 86. Jubilant Description and Business Overview
Table 87. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Jubilant Pharmaceutical Intermediates Product
Table 89. Jubilant Recent Development
Table 90. Granules Company Information
Table 91. Granules Description and Business Overview
Table 92. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Granules Pharmaceutical Intermediates Product
Table 94. Granules Recent Development
Table 95. Ganesh Company Information
Table 96. Ganesh Description and Business Overview
Table 97. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Ganesh Pharmaceutical Intermediates Product
Table 99. Ganesh Recent Development
Table 100. Chemcon Company Information
Table 101. Chemcon Description and Business Overview
Table 102. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Chemcon Pharmaceutical Intermediates Product
Table 104. Chemcon Recent Development
Table 105. BASF Company Information
Table 106. BASF Description and Business Overview
Table 107. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. BASF Pharmaceutical Intermediates Product
Table 109. BASF Recent Development
Table 110. Porton Company Information
Table 111. Porton Description and Business Overview
Table 112. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Porton Pharmaceutical Intermediates Product
Table 114. Porton Recent Development
Table 115. Lianhetech Company Information
Table 116. Lianhetech Description and Business Overview
Table 117. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Lianhetech Pharmaceutical Intermediates Product
Table 119. Lianhetech Recent Development
Table 120. ABA Chem Company Information
Table 121. ABA Chem Description and Business Overview
Table 122. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. ABA Chem Pharmaceutical Intermediates Product
Table 124. ABA Chem Recent Development
Table 125. Tianma Company Information
Table 126. Tianma Description and Business Overview
Table 127. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 128. Tianma Pharmaceutical Intermediates Product
Table 129. Tianma Recent Development
Table 130. Jiujiujiu Company Information
Table 131. Jiujiujiu Description and Business Overview
Table 132. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 133. Jiujiujiu Pharmaceutical Intermediates Product
Table 134. Jiujiujiu Recent Development
Table 135. Alpha Company Information
Table 136. Alpha Description and Business Overview
Table 137. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 138. Alpha Pharmaceutical Intermediates Product
Table 139. Alpha Recent Development
Table 140. Jiuzhou Company Information
Table 141. Jiuzhou Description and Business Overview
Table 142. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 143. Jiuzhou Pharmaceutical Intermediates Product
Table 144. Jiuzhou Recent Development
Table 145. Yongtai Company Information
Table 146. Yongtai Description and Business Overview
Table 147. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 148. Yongtai Pharmaceutical Intermediates Product
Table 149. Yongtai Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Pharmaceutical Intermediates Distributors List
Table 153. Pharmaceutical Intermediates Customers List
Table 154. Pharmaceutical Intermediates Market Trends
Table 155. Pharmaceutical Intermediates Market Drivers
Table 156. Pharmaceutical Intermediates Market Challenges
Table 157. Pharmaceutical Intermediates Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Pharmaceutical Intermediates Sales Market Share by Type in 2024 & 2031
Figure 4. GMP Product Picture
Figure 5. Non-GMP Product Picture
Figure 6. Global Pharmaceutical Intermediates Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Pharmaceutical Intermediates Sales Market Share by Application in 2024 & 2031
Figure 8. Antibiotics Examples
Figure 9. Antipyretic Analgesics Examples
Figure 10. Vitamins Examples
Figure 11. Others Examples
Figure 12. Global Pharmaceutical Intermediates Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pharmaceutical Intermediates Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Pharmaceutical Intermediates Sales (K MT) Growth Rate (2020-2031)
Figure 15. Global Pharmaceutical Intermediates Price Trends Growth Rate (2020-2031) & (USD/MT)
Figure 16. Pharmaceutical Intermediates Report Years Considered
Figure 17. Global Market Pharmaceutical Intermediates Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Pharmaceutical Intermediates Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Pharmaceutical Intermediates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Pharmaceutical Intermediates Sales (K MT) Growth Rate (2020-2031)
Figure 21. Europe Pharmaceutical Intermediates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Pharmaceutical Intermediates Sales (K MT) Growth Rate (2020-2031)
Figure 23. China Pharmaceutical Intermediates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Pharmaceutical Intermediates Sales (K MT) Growth Rate (2020-2031)
Figure 25. India Pharmaceutical Intermediates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. India Pharmaceutical Intermediates Sales (K MT) Growth Rate (2020-2031)
Figure 27. Global Pharmaceutical Intermediates Revenue Share by Type (2020-2025)
Figure 28. Global Pharmaceutical Intermediates Sales Share by Type (2026-2031)
Figure 29. Global Pharmaceutical Intermediates Revenue Share by Type (2026-2031)
Figure 30. Global Pharmaceutical Intermediates Revenue Share by Application (2020-2025)
Figure 31. Global Pharmaceutical Intermediates Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Pharmaceutical Intermediates Sales Share by Application (2026-2031)
Figure 33. Global Pharmaceutical Intermediates Revenue Share by Application (2026-2031)
Figure 34. Global Pharmaceutical Intermediates Sales Share by Company (2024)
Figure 35. Global Pharmaceutical Intermediates Revenue Share by Company (2024)
Figure 36. Global 5 Largest Pharmaceutical Intermediates Players Market Share by Revenue in Pharmaceutical Intermediates: 2020 & 2024
Figure 37. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Pharmaceutical Intermediates
Figure 39. Manufacturing Process Analysis of Pharmaceutical Intermediates
Figure 40. Pharmaceutical Intermediates Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pharmaceutical Intermediates market?
The top companies in the global Pharmaceutical Intermediates market are Lonza、Catalent、Patheon.
What is the annual compound growth rate of the global Pharmaceutical Intermediates market size from 2025 to 2031?
What was the global market size of Pharmaceutical Intermediates in 2031?
Which region is expected to have the highest market share?
What was the global market size of Pharmaceutical Intermediates in 2025?
Related Reports
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-16
Pages: 173
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-17
Pages: 177
USD 5600.00
(Single User License)
Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-07
Pages: 117
USD 4900.00
(Single User License)
Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-01-16
Pages: 99
USD 2900.00
(Single User License)
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 143
USD 3950.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 178
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 172
USD 4900.00
(Single User License)
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 147
USD 3950.00
(Single User License)
Global Pharmaceutical Intermediates Market Research Report 2026
The global Pharmaceutical Intermediates market was valued at US$ 217230 million in 2025 and is anticipated to reach US$ 331190 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 136
USD 2900.00
(Single User License)
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-16
Pages: 173
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-17
Pages: 177
USD 5600.00 (Single User License)Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-07
Pages: 117
USD 4900.00 (Single User License)Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-01-16
Pages: 99
USD 2900.00 (Single User License)Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 143
USD 3950.00 (Single User License)Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 178
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 172
USD 4900.00 (Single User License)Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 147
USD 3950.00 (Single User License)Global Pharmaceutical Intermediates Market Research Report 2026
The global Pharmaceutical Intermediates market was valued at US$ 217230 million in 2025 and is anticipated to reach US$ 331190 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 136
USD 2900.00 (Single User License)Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
Why This Report?
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report